Cleared Traditional

K150329 - elance Vital Signs Monitor, Central Monitor Software

K150329 is an FDA 510(k) clearance for elance Vital Signs Monitor, manufactured by Spacelabs Healthcare. The device is a Class 2 Cardiovascular device with product code MHX cleared through the Traditional 510(k) pathway after a 268-day FDA review.

K150329 · Spacelabs Healthcare · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Nov 2015
Decision
268d
Days
Class 2
Risk

K150329 is an FDA 510(k) clearance for the elance Vital Signs Monitor, Central Monitor Software. Classified as Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (product code MHX), Class II - Special Controls.

Submitted by Spacelabs Healthcare (Snoqualmie, US). The FDA issued a Cleared decision on November 5, 2015 after a review of 268 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K150329

510(k) Number K150329 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 10, 2015
Decision Date November 05, 2015
Days to Decision 268 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
143d slower than avg
Panel avg: 125d · This submission: 268d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MHX Device Classification - Class 2, Special Controls

Product Code MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Speed TO Market, Inc.
Thomas Kroenke

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)

All 421
Devices cleared under the same product code (MHX) and FDA review panel - the closest regulatory comparables to K150329.
Passport Series Patient Monitors (including Passport 17m, Passport 12m and T1)
K152902 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Feb 2016
PATIENT MONITORS VARIOUS MODELS
K151812 · Philips Medical Systems · Jan 2016
Monitor B40
K151063 · Ge Medical Systems China Co., Ltd. · Dec 2015
Nihon Kohden CSM 1901 Bedside Monitor
K151080 · Nihon Kohden · Nov 2015
zensor system
K151027 · Intelesens Limited · Oct 2015
Infinity Delta, Infinity Delta XL, Infinity Kappa
K152407 · Draeger Medical Sytems, Inc. · Sep 2015